SABR Combined With Axitinib and Toripalimab for Oligometastatic Renal Cell Carcinoma
SABR Combined With Axitinib and Toripalimab for Oligometastatic Renal Cell Carcinoma
Recruiting · NCT07744932 · Registry updated 2026-08-04Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SABR Combined With Axitinib and Toripalimab for Oligometastatic Renal Cell Carcinoma | Oligometastatic Clear Cell Renal Cell Carcinoma | Recruiting | Phase 2 | 2026-08-04 | NCT07744932 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hebei Medical University Fourth Hospital | 83 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Fourth Hospital of Hebei Medical University | Shijiazhuang | China | 30 |